Prevalence of CTX-M
Anti-Bacterial Agents
/ therapeutic use
Cross-Sectional Studies
Drug Resistance, Multiple, Bacterial
/ drug effects
Escherichia coli
/ drug effects
Escherichia coli Infections
/ drug therapy
Female
Hospitals
Humans
Klebsiella Infections
/ drug therapy
Klebsiella pneumoniae
/ drug effects
Male
Microbial Sensitivity Tests
/ methods
Nepal
Prevalence
beta-Lactamases
/ metabolism
Journal
BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173
Informations de publication
Date de publication:
2021
2021
Historique:
received:
01
04
2021
accepted:
29
05
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
29
9
2021
Statut:
epublish
Résumé
The emergence of multidrug resistant (MDR) bacteria which is attributable to extended spectrum
Identifiants
pubmed: 34212045
doi: 10.1155/2021/9958294
pmc: PMC8208866
doi:
Substances chimiques
Anti-Bacterial Agents
0
beta-Lactamases
EC 3.5.2.6
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
9958294Informations de copyright
Copyright © 2021 Sushma Koirala et al.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to declare.
Références
Infection. 1990 Sep-Oct;18(5):294-8
pubmed: 2276823
BMC Res Notes. 2014 Oct 07;7:694
pubmed: 25287013
J Clin Microbiol. 1997 Sep;35(9):2315-9
pubmed: 9276409
Lancet Infect Dis. 2013 Dec;13(12):1057-98
pubmed: 24252483
BMC Infect Dis. 2018 Oct 20;18(1):524
pubmed: 30342476
Antimicrob Resist Infect Control. 2019 May 22;8:80
pubmed: 31139363
Front Microbiol. 2012 Apr 02;3:110
pubmed: 22485109
BMC Res Notes. 2020 Nov 10;13(1):520
pubmed: 33172496
Antimicrob Agents Chemother. 2010 Mar;54(3):969-76
pubmed: 19995920
Clin Microbiol Infect. 2008 Jan;14 Suppl 1:134-43
pubmed: 18154537
Int J Med Microbiol. 2013 Aug;303(6-7):305-17
pubmed: 23490927
BMC Res Notes. 2019 Aug 16;12(1):516
pubmed: 31420003
Sci Rep. 2019 Mar 12;9(1):4224
pubmed: 30862858
Pediatr Int. 2012 Dec;54(6):858-62
pubmed: 22882781
Science. 1994 Apr 15;264(5157):375-82
pubmed: 8153624
Clin Microbiol Rev. 2013 Oct;26(4):744-58
pubmed: 24092853
Int J Microbiol. 2020 Oct 29;2020:8877200
pubmed: 33488730
Ann Clin Microbiol Antimicrob. 2017 Sep 19;16(1):62
pubmed: 28927454
Infect Dis Clin North Am. 2016 Jun;30(2):523-537
pubmed: 27208771
Biomed Res Int. 2016;2016:1782835
pubmed: 28119921
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Kathmandu Univ Med J (KUMJ). 2020 Jan.-Mar;18(69):23-27
pubmed: 33582683
Front Microbiol. 2011 Sep 28;2:203
pubmed: 22046172
Open Microbiol J. 2018 Jul 31;12:230-242
pubmed: 30197696
Infect Dis (Auckl). 2020 Aug 28;13:1178633720952077
pubmed: 32922030
Diagn Microbiol Infect Dis. 2000 Sep;38(1):59-67
pubmed: 11025185
Clin Infect Dis. 2009 Sep 1;49(5):682-90
pubmed: 19622043
N Engl J Med. 2005 Jan 27;352(4):380-91
pubmed: 15673804
J Antimicrob Chemother. 2004 Aug;54(2):406-9
pubmed: 15201232
Antimicrob Resist Infect Control. 2019 Feb 15;8:39
pubmed: 30815254
Infect Ecol Epidemiol. 2014 Oct 01;4:
pubmed: 25317262
J Nat Sci Biol Med. 2014 Jan;5(1):30-5
pubmed: 24678193
Open Microbiol J. 2017 Apr 28;11:23-30
pubmed: 28553414